Balance Sheet StrengthHABA's strong equity base and low leverage provide a durable financial cushion. Low debt-to-equity reduces refinancing and solvency risk, supporting capital allocation for operations, dividends or selective investment over the next several months even if revenue remains pressured.

Improving Operating Cash FlowRecent improvement in operating cash flow indicates better cash conversion from core operations. That enhances short-to-medium term liquidity, supports working capital and discretionary spending, and partially offsets prior free cash flow volatility when sustaining operations or funding initiatives.

Robust Gross MarginsSustained strong gross margins point to effective pricing or cost control in core product lines. This structural margin buffer helps absorb revenue softness, supports operating leverage recovery, and preserves capacity to invest in marketing or product development to stabilize growth.

Bears Say

Declining Revenue TrendA negative revenue growth trend reduces scale and puts pressure on fixed-cost absorption. Persistent top-line contraction constrains reinvestment, weakens negotiating leverage with suppliers, and makes it harder to restore margins and earnings, posing a sustained medium-term growth risk.

Volatile ProfitabilitySignificant swings in net income and erratic EBIT/EBITDA margins indicate unstable operating performance. This unpredictability complicates planning, capital allocation and dividend policy, and suggests structural issues in demand, pricing, or cost control that may persist absent strategic fixes.

Inconsistent Free Cash Flow GrowthStruggles to grow free cash flow historically reduce flexibility for investments, debt reduction and shareholder returns. Even with recent OCF improvement, inconsistent FCF undermines confidence in sustainable internal funding and creates execution risk over the next several quarters.

4925 FAQ

What was HABA Laboratories, Inc.’s price range in the past 12 months?

HABA Laboratories, Inc. lowest stock price was ¥1520.00 and its highest was ¥1888.00 in the past 12 months.

What is HABA Laboratories, Inc.’s market cap?

HABA Laboratories, Inc.’s market cap is ¥6.91B.

When is HABA Laboratories, Inc.’s upcoming earnings report date?

HABA Laboratories, Inc.’s upcoming earnings report date is May 08, 2026 which is in 60 days.

How were HABA Laboratories, Inc.’s earnings last quarter?

HABA Laboratories, Inc. released its earnings results on Feb 06, 2026. The company reported ¥34.53 earnings per share for the quarter, beating the consensus estimate of N/A by ¥34.53.

Is HABA Laboratories, Inc. overvalued?

According to Wall Street analysts HABA Laboratories, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does HABA Laboratories, Inc. pay dividends?

HABA Laboratories, Inc. pays a Annually dividend of ¥40 which represents an annual dividend yield of 2.38%. See more information on HABA Laboratories, Inc. dividends here

What is HABA Laboratories, Inc.’s EPS estimate?

HABA Laboratories, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does HABA Laboratories, Inc. have?

HABA Laboratories, Inc. has 3,935,000 shares outstanding.

What happened to HABA Laboratories, Inc.’s price movement after its last earnings report?

HABA Laboratories, Inc. reported an EPS of ¥34.53 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.173%.

Which hedge fund is a major shareholder of HABA Laboratories, Inc.?

Currently, no hedge funds are holding shares in JP:4925

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

HABA Laboratories, Inc.

HABA Laboratories,Inc. manufactures and sells skin care, and hair and body care products in Japan and internationally. Its skin care products include cleansers/face washes, toners, special care products, and squalane oils; and hair and body care products comprise shampoos, conditioners, soaps, and hair and hand treatment products. The company sells its products through mail order, shops, drug/variety stores, and internet. It has approximately 70 HABA shops located in department stores, shopping malls, etc. HABA Laboratories,Inc. was founded in 1983 and is headquartered in Tokyo, Japan.